The Regulatory Guideline for the Implementation of the Egyptian Drug Authority Chairman's Decree No. 388/2023 for the Registration of Innovative Products
OFFICIAL SOURCE FACTS / REQUIREMENT FRAMEWORK
What you need to know
EDA version 02 implements Decree 388/2023 for innovative-product registration. It was issued 7 September 2026 and is effective from 1 October 2026.
Its scope defines product, applicant and manufacturing conditions. This brief does not establish eligibility.
This summary is not a complete regulatory checklist. Applicability, conditions and exclusions remain governed by the original official document.
Who is affected
Product developers
Manufacturers
Regulatory Affairs teams
PHARMA GATE INTERPRETATION — NOT AN OFFICIAL REQUIREMENT
Pharma Gate Intelligence
A product described commercially as innovative is not automatically eligible for this pathway. Check the official classification and scope first.
Business impact
Eligibility assessment should precede dossier and evidence commitments.
RECOMMENDED ACTION — NOT A REGULATORY DETERMINATION
What to check
Product and regulatory classification
Scope and applicable eligibility conditions
Current dossier and evidence provisions
Recommended next step
Obtain a product-specific assessment of the current EDA pathway.
Pharma Gate is not a regulatory authority. Professional providers are independent organizations subject to platform review.
VERIFIED SOURCE GOVERNANCE
Official facts are attributed to issuing authorities. Pharma Gate analysis and recommended actions are clearly separated.
How we verify intelligence
Official facts are attributed to the issuing organization. Pharma Gate interpretation and recommended actions are separate editorial layers, not legal requirements or regulatory approval. Sources are prioritized: national regulators, WHO and recognized intergovernmental bodies, official procurement organizations, then other official governmental or institutional sources.
Publication records retain source title, version, issue date, verification date, country, sector and status. Draft / Public Consultation is distinct from Current. Superseded and Archived records do not represent current requirements. A verification date records the review performed; it is not an assurance of continuous monitoring. Always check the latest official source before acting.
